Drug Profile
SJP 0008
Alternative Names: SJP-0008Latest Information Update: 28 Oct 2018
Price :
$50
*
At a glance
- Originator Senju Pharmaceutical
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Oct 2018 No recent reports of development identified for phase-I development in Undefined(In volunteers) in Japan (PO)
- 24 Sep 2015 Phase-I clinical trials in Undefined indication (In volunteers) in Japan (PO) (UMIN000019104)